Seattle, Oct. 26, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global non-invasive prenatal testing market is estimated to be valued at US$ 1,350.9 million in 2022 and is expected to exhibit a CAGR of 18.5% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Non-invasive Prenatal Testing Market:
Major players in the global non-invasive prenatal testing market are focused on launching new products to expand their product portfolio. For instance, in August 2019, Axia Women’s Health, a U.S.-based independent women’s healthcare group, launched Precision non-invasive prenatal testing (NIPT) in the U.S.
The test used blood sample from pregnant mother to analyze the Deoxyribonucleic acid (DNA) of the fetus in order to investigate the chromosomal abnormalities. The Precision NIPT identify and differentiate between the mother and fetus DNA and screen variety of chromosomal conditions such as Down Syndrome, Patau Syndrome, Edward Syndrome, and others.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/579
Key Market Takeaways:
The global non-invasive prenatal testing market is expected to exhibit a CAGR of 18.5 % during the forecast period due to increasing prevalence of birth defects due to different chromosomal abnormalities. For instance, according to the World Health Organization Facts Sheet February 2022, around 240,000 newborns die worldwide within few days of birth each year due to birth defects and the most common defects are heart defects, neural defects and Down Syndrome which cause due to chromosomal abnormalities.
Among applications, sex chromosomes abnormalities segment is expected to hold a dominant position over the forecast period, owing to increasing in product launch and new product development. For instance, in September 2022, Eurofins Genoma, Part of Eurofins Network of companies, one of the most advanced European molecular diagnostics laboratories, announces the launch of niPFT-A, a non-invasive genetic aneuploidy screening test, to detect the missing chromosomes in the genetic makeup. This niPGT-A provides IVF centers with access to highly accurate alternative to traditional PGT-A. It uses embryonic cell-free DNA to evaluate embryo ploidy.
Among Region, North America is expected to hold a dominant position over the forecast period, owing to increasing efforts by the key players to increase research and development in field of non-invasive prenatal tests. For instance, in October, 2019, PerkinElmer Inc., a company that provides products, services, and solutions for the diagnostics, life sciences, and applied markets, announced that it has started to process the bold samples for genetic anomalies using its non-invasive prenatal test, Vanadis at CLIA lab.
Competitive Landscape:
Key players operating in the global non-invasive prenatal testing market include F. Hoffmann-La Roche Ltd, BGI Group, Berry Genomics Co., Ltd., Illumina, Inc., Eurofin Scientific , Natera, Inc., Sequenom, Inc. ,Axia Women’s Health , Eluthia, BillionToOne, Inc., Quest Diagnostics Incorporation, Igenomix, Agilent Technologies, Inc, Laboratory Corporation of America Holdings., PerkinElmer, Inc., Thermo Fisher Scientific, Yourgene Health PLC
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/579
Market Segmentation:
- Global Non-Invasive Prenatal Testing Market, By Test Type:
- Panel 1 Test
- Panel 2 Test
- Panel 3 Test
- Global Non-Invasive Prenatal Testing Market, By Application:
- Trisomy
- Microdeletion Syndrome
- Sex Chromosome abnormalities
- Other
- Global Non-Invasive Prenatal Testing Market, By End User:
- Hospitals
- Diagnostic Laboratories
- Maternity Centers
- Global Non-Invasive Prenatal Testing Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- North Africa
- Central Africa
- South Africa
- By Country
- North America
Related Market Intelligence Reports:
Self-Testing Market, by Product Type (Kits (Self-testing kits, Self-collection kits) Self-testing Devices), by Application Type (Blood Glucose Testing, Pregnancy Testing, Pulmonary Function Testing, Urinary Tract Infection Testing, Sexually transmitted infections (STIs) Testing, Genetic Testing, Vitamin and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe Sample)), by Test Type (Laboratory Tests, Point of Care Tests/Homecare Tests), by Distribution Channel (Offline (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Supermarkets and Hypermarket) and Online), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
Metabolic Testing Market, by Product Type (Metabolic Carts (Portable and Bench-top), Body Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable and Bench-top)), by Test Type (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis), by End User (Hospitals & Clinics, Sports Performance Lab, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
